Statement by HLC President Mary R. Grealy on the FDA’s Emergency Use Authorization Decision for the Johnson & Johnson COVID-19 Vaccine

With the FDA’s decision to grant an Emergency Use Authorization for the COVID-19 vaccine developed by Johnson & Johnson, our nation is another step closer to regaining health, safety, and normalcy after a long year of struggle with this deadly virus. The swiftness with which the Pfizer/BioNTech, Moderna and J&J vaccines were created is a testament to a biopharmaceutical industry defined by robust innovation and a commitment to public health.

As distribution of vaccines continues to ramp up and they become more widely available, it is critical that Americans get their shots as soon as they can. There should be no hesitancy over taking vaccines that have been thoroughly reviewed by medical and scientific experts and are safe and effective. We can see the light at the end of this tunnel and these vaccines are the key to reaching it as swiftly as possible.




For Immediate Release
February 27, 2021
Contact: Kelly Fernandez  202-449-3452